Evidence map›Paper›PMID 25372144›Full record

ArticlePloS one2014

Zolpidem reduces hippocampal neuronal activity in freely behaving mice: a large scale calcium imaging study with miniaturized fluorescence microscope.

Tamara Berdyyeva, Stephani Otte, Leah Aluisio, Yaniv Ziv, Laurie D Burns, Christine Dugovic, Sujin Yun, Kunal K Ghosh, Mark J Schnitzer, Timothy Lovenberg and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 2 pooled it
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 2 syntheses or guidelines pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Use of Drugs Affecting GABAMolecular neurobiology · 2025
    Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Real-Time Prosthetic Digit Actuation by Optical Read-out of Activity-Dependent Calcium Signals in an Ex Vivo Peripheral Nerve.International IEEE/EMBS Conference on Neural Engineering : [proceedings]. International IEEE EMBS Conference on Neural Engineering · 2019
    Article
  13. Frontiers in neuroscience · 2019
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Implications of gamma band activity in the pedunculopontine nucleus.Journal of neural transmission (Vienna, Austria : 1996) · 2016
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Tamara BerdyyevaJanssen Research & Development, LLC, San Diego, California, United States of America.
Stephani OtteInscopix, Palo Alto, California, United States of America.
Leah AluisioJanssen Research & Development, LLC, San Diego, California, United States of America.
Yaniv ZivInscopix, Palo Alto, California, United States of America.
Laurie D BurnsInscopix, Palo Alto, California, United States of America.
Christine DugovicJanssen Research & Development, LLC, San Diego, California, United States of America.
Sujin YunJanssen Research & Development, LLC, San Diego, California, United States of America.
Kunal K GhoshInscopix, Palo Alto, California, United States of America.
Mark J SchnitzerInscopix, Palo Alto, California, United States of America.
Timothy LovenbergJanssen Research & Development, LLC, San Diego, California, United States of America.
Pascal BonaventureJanssen Research & Development, LLC, San Diego, California, United States of America.
Janssen (United States) · USInscopix (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Therapeutic drugs for cognitive and psychiatric disorders are often characterized by their molecular mechanism of action. Here we demonstrate a new approach to elucidate drug action on large-scale neuronal activity by tracking somatic calcium dynamics in hundreds of CA1 hippocampal neurons of pharmacologically manipulated behaving mice. We used an adeno-associated viral vector to express the calcium sensor GCaMP3 in CA1 pyramidal cells under control of the CaMKII promoter and a miniaturized microscope to observe cellular dynamics. We visualized these dynamics with and without a systemic administration of Zolpidem, a GABAA agonist that is the most commonly prescribed drug for the treatment of insomnia in the United States. Despite growing concerns about the potential adverse effects of Zolpidem on memory and cognition, it remained unclear whether Zolpidem alters neuronal activity in the hippocampus, a brain area critical for cognition and memory. Zolpidem, when delivered at a dose known to induce and prolong sleep, strongly suppressed CA1 calcium signaling. The rate of calcium transients after Zolpidem administration was significantly lower compared to vehicle treatment. To factor out the contribution of changes in locomotor or physiological conditions following Zolpidem treatment, we compared the cellular activity across comparable epochs matched by locomotor and physiological assessments. This analysis revealed significantly depressive effects of Zolpidem regardless of the animal's state. Individual hippocampal CA1 pyramidal cells differed in their responses to Zolpidem with the majority (∼ 65%) significantly decreasing the rate of calcium transients, and a small subset (3%) showing an unexpected and significant increase. By linking molecular mechanisms with the dynamics of neural circuitry and behavioral states, this approach has the potential to contribute substantially to the development of new therapeutics for the treatment of CNS disorders.

Indexed as

CA1 Region, HippocampalPyramidal CellsAnimalsBehavior, AnimalCalciumGABA-A Receptor AgonistsLocomotionMiceMicroscopy, FluorescenceMolecular ImagingOptical ImagingPyridinesZolpidemCalciumGABA-A Receptor AgonistsPyridinesZolpidem

Identifiers

PMID25372144
PMCPMC4221229
OpenAlexW1972809394

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.